Suppr超能文献

患者是罕见病诊断和研究的伙伴。

Patients as Partners in Rare Disease Diagnosis and Research.

机构信息

Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

出版信息

Yale J Biol Med. 2021 Dec 29;94(4):687-692. eCollection 2021 Dec.

Abstract

There is great value in understanding the patient perspective in rare disease diagnosis and research, and in partnering actively with patients and their families throughout the process. Meaningful and respectful interaction between patients and researchers leads to learning on both sides, and ultimately, to better research outcomes. Researchers can help patients understand how research is conducted and what the latest advances and perceived gaps in research are, and patients, who have direct experience living with their health conditions, can impart to researchers what is most important to them. We describe our engagement with patients in the Undiagnosed Diseases Network (UDN) program, as well as the lessons we have learned to date. In the UDN, patients have been instrumental in bringing meaning to the work of clinicians and researchers, building patient communities, making the network aware of unmet patient needs, advocating for additional research funding, and disseminating UDN research findings. Although patient engagement in the UDN has already had a significant positive impact on our work, we continue to strive to involve patients earlier in the process, in the research design itself, and in addressing power dynamics that may arise between clinicians, researchers, and patients.

摘要

了解罕见病诊断和研究中的患者视角,并在整个过程中积极与患者及其家属合作,具有重要价值。患者和研究人员之间有意义和尊重的互动可以促进双方的学习,最终可以带来更好的研究结果。研究人员可以帮助患者了解研究是如何进行的,以及最新的进展和感知到的研究差距是什么,而患者直接有经验地生活在他们的健康状况中,可以向研究人员传授对他们最重要的东西。我们描述了我们在未确诊疾病网络(UDN)计划中与患者的接触,以及迄今为止我们所学到的经验教训。在 UDN 中,患者在为临床医生和研究人员的工作赋予意义、建立患者社区、使网络了解未满足的患者需求、倡导增加研究资金以及传播 UDN 研究结果方面发挥了重要作用。尽管患者在 UDN 中的参与已经对我们的工作产生了重大的积极影响,但我们仍继续努力让患者更早地参与到这个过程中,参与到研究设计本身中,并解决临床医生、研究人员和患者之间可能出现的权力动态问题。

相似文献

1
Patients as Partners in Rare Disease Diagnosis and Research.
Yale J Biol Med. 2021 Dec 29;94(4):687-692. eCollection 2021 Dec.
2
Participation in a national diagnostic research study: assessing the patient experience.
Orphanet J Rare Dis. 2023 Apr 10;18(1):73. doi: 10.1186/s13023-023-02695-5.
3
Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.
JAMA Netw Open. 2021 Feb 1;4(2):e2036220. doi: 10.1001/jamanetworkopen.2020.36220.
4
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Characteristics of undiagnosed diseases network applicants: implications for referring providers.
BMC Health Serv Res. 2018 Aug 22;18(1):652. doi: 10.1186/s12913-018-3458-2.
6
A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network.
Orphanet J Rare Dis. 2017 Apr 17;12(1):71. doi: 10.1186/s13023-017-0623-3.
8
Data sharing in the undiagnosed diseases network.
Hum Mutat. 2015 Oct;36(10):985-8. doi: 10.1002/humu.22840. Epub 2015 Aug 27.
9
The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease.
Am J Hum Genet. 2017 Feb 2;100(2):185-192. doi: 10.1016/j.ajhg.2017.01.006.
10
The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
JBI Database System Rev Implement Rep. 2015 Jan;13(1):76-87. doi: 10.11124/jbisrir-2015-1072.

引用本文的文献

2
Knowledge and Attitudes of Clinical Trials among Patients with Rare Diseases and the Guardians in China.
Ther Innov Regul Sci. 2024 Jan;58(1):53-62. doi: 10.1007/s43441-023-00571-9. Epub 2023 Sep 18.
3
Together4RD position statement on collaboration between European reference networks and industry.
Orphanet J Rare Dis. 2023 Sep 5;18(1):272. doi: 10.1186/s13023-023-02853-9.

本文引用的文献

2
Next-generation sequencing and the evolution of data sharing.
Am J Med Genet A. 2021 Sep;185(9):2633-2635. doi: 10.1002/ajmg.a.62239. Epub 2021 May 7.
3
The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
Res Involv Engagem. 2020 Oct 27;6:63. doi: 10.1186/s40900-020-00239-w. eCollection 2020.
4
Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science.
Genet Med. 2021 Feb;23(2):259-271. doi: 10.1038/s41436-020-00984-z. Epub 2020 Oct 23.
5
Genomic Data Sharing for Novel Mendelian Disease Gene Discovery: The Matchmaker Exchange.
Annu Rev Genomics Hum Genet. 2020 Aug 31;21:305-326. doi: 10.1146/annurev-genom-083118-014915. Epub 2020 Apr 27.
6
Learning as an outcome of involvement in research: what are the implications for practice, reporting and evaluation?
Res Involv Engagem. 2019 Mar 12;5:14. doi: 10.1186/s40900-019-0147-1. eCollection 2019.
7
Patient Engagement In Research: Early Findings From The Patient-Centered Outcomes Research Institute.
Health Aff (Millwood). 2019 Mar;38(3):359-367. doi: 10.1377/hlthaff.2018.05067.
9
Evaluating patient and public involvement in research.
BMJ. 2018 Dec 6;363:k5147. doi: 10.1136/bmj.k5147.
10
Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease.
N Engl J Med. 2018 Nov 29;379(22):2131-2139. doi: 10.1056/NEJMoa1714458. Epub 2018 Oct 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验